New HIV cocktail shows promise in early trial
NCT ID NCT00122603
First seen Apr 03, 2026 · Last updated May 21, 2026 · Updated 10 times
Summary
This study tested two different two-drug combinations in 61 adults with HIV who had not taken protease inhibitors before. The goal was to see if these combos could lower the virus to undetectable levels after 16 weeks. Researchers also watched for side effects and changes in body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service des Maladies infectieuses et tropicales Hopital Bichat Claude Bernard
Paris, 75018, France
Conditions
Explore the condition pages connected to this study.